Serotonin Syndrome in Pregnancy

Area of Science:

• Pharmacology
• Clinical Medicine
• Neuroscience

Background:

• Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed for depression and anxiety.
• Potential drug interactions in obstetric settings pose a risk for serotonin syndrome.
• Serotonin syndrome is a serious condition requiring clinical awareness.

Purpose of the Study:

• To highlight the risk of serotonin syndrome in women using SSRIs.
• To inform clinicians about potential medication interactions during labor and postpartum.
• To emphasize the importance of recognizing serotonin syndrome symptoms for timely intervention.

Main Methods:

• Literature review on SSRI use and serotonin syndrome.
• Analysis of case reports and clinical guidelines.
• Synthesis of information on drug interactions in obstetric care.

Main Results:

• SSRI use combined with other medications can precipitate serotonin syndrome.
• Symptoms include acute onset of delirium, fever, and hypertension.
• Early recognition is crucial for effective management.

Conclusions:

• Nurses and clinicians must be vigilant for serotonin syndrome in patients on SSRIs.
• Awareness of drug interactions in labor and postpartum settings is critical.
• Understanding the syndrome facilitates prompt diagnosis and treatment.